Minnow Street Minnow Street
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

ANI Pharmaceuticals Inc (ANIP)

Healthcare Drug Manufacturers - Specialty & Generic
79.20 $
-1.5% vs. previous close
Closing price · As of: 31. Jul 2026

Who owns ANI Pharmaceuticals Inc (ANIP)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 85.4% of the shares are freely tradable; institutional investors hold 110.4%.

Ownership Structure

Institutional ownership
110.4%
Insiders
5.6%
Float
85.4%
Short % of float
17.2%
Shares Outstanding
23Mio.

Largest Shareholders

Institutions

Institutions ANIP
Name Stake (%) Shares Change (%) Date
BlackRock Inc 12.09 2,747,492 +3.2 03/31/2026
Vanguard Group Inc 5.74 1,305,068 +2.2 12/31/2025
Vanguard Capital Management, LLC 3.62 823,064 +0.0 03/31/2026
Soleus Capital Management, L.P. 3.61 820,243 +68.7 03/31/2026
State Street Corp 3.39 771,587 +6.1 03/31/2026
TANG CAPITAL MANAGEMENT LLC 3.11 707,500 +47.0 03/31/2026
Goldentree Asset Management LP 2.94 667,981 +0.0 03/31/2026
Deep Track Capital, LP 2.64 600,000 +25.6 03/31/2026

Funds

Funds ANIP
Name Stake (%) Shares Change (%) Date
iShares Core S&P Small-Cap ETF 4.79 1,089,566 +0.0 05/29/2026
Vanguard Total Stock Mkt Idx Inv 2.64 600,933 +0.0 04/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
29. Jul 2026 Carey Stephen P. SVP & CFO Sell 2,850 81.36 231,876
18. Jul 2026 Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Other 2,466 79.20 195,307
13. Jul 2026 Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sell 500 81.84 40,920

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

View all insider transactions →

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?